Central Trust Company’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $140K | Sell |
742
-1
| -0.1% | -$175 | ﹤0.01% | 652 |
|
|
2025
Q4 | $126K | Sell |
743
-19
| -2% | -$2.91K | ﹤0.01% | 663 |
|
|
2025
Q3 | $100K | Sell |
762
-703
| -48% | -$84.3K | ﹤0.01% | 692 |
|
|
2025
Q2 | $155K | Sell |
1,465
-230
| -14% | -$25K | ﹤0.01% | 607 |
|
|
2025
Q1 | $210K | Sell |
1,695
-2
| -0.1% | -$261 | 0.01% | 550 |
|
|
2024
Q4 | $209K | Sell |
1,697
-389
| -19% | -$45.8K | 0.01% | 555 |
|
|
2024
Q3 | $232K | Sell |
2,086
-577
| -22% | -$63.2K | 0.01% | 531 |
|
|
2024
Q2 | $284K | Sell |
2,663
-1,162
| -30% | -$128K | 0.01% | 496 |
|
|
2024
Q1 | $461K | Sell |
3,825
-2,621
| -41% | -$321K | 0.01% | 427 |
|
|
2023
Q4 | $793K | Sell |
6,446
-1,015
| -14% | -$127K | 0.02% | 349 |
|
|
2023
Q3 | $966K | Sell |
7,461
-2,767
| -27% | -$369K | 0.03% | 320 |
|
|
2023
Q2 | $1.27M | Sell |
10,228
-4,914
| -32% | -$661K | 0.04% | 278 |
|
|
2023
Q1 | $2.22M | Sell |
15,142
-286
| -2% | -$42.3K | 0.06% | 211 |
|
|
2022
Q4 | $2.46M | Buy |
15,428
+398
| +3% | +$58.3K | 0.08% | 201 |
|
|
2022
Q3 | $2M | Sell |
15,030
-1,521
| -9% | -$231K | 0.07% | 205 |
|
|
2022
Q2 | $2.58M | Buy |
16,551
+2,530
| +18% | +$389K | 0.09% | 185 |
|
|
2022
Q1 | $2.18M | Sell |
14,021
-121
| -0.9% | -$17.6K | 0.06% | 228 |
|
|
2021
Q4 | $1.8M | Buy |
14,142
+1,949
| +16% | +$256K | 0.05% | 260 |
|
|
2021
Q3 | $1.59M | Sell |
12,193
-580
| -5% | -$87.6K | 0.06% | 252 |
|
|
2021
Q2 | $2.27M | Sell |
12,773
-1,048
| -8% | -$182K | 0.08% | 210 |
|
|
2021
Q1 | $2.27M | Sell |
13,821
-1,051
| -7% | -$173K | 0.09% | 194 |
|
|
2020
Q4 | $2.45M | Sell |
14,872
-420
| -3% | -$62.6K | 0.1% | 166 |
|
|
2020
Q3 | $2.18M | Sell |
15,292
-259
| -2% | -$32.1K | 0.1% | 161 |
|
|
2020
Q2 | $1.72M | Buy |
15,551
+2,195
| +16% | +$243K | 0.09% | 179 |
|
|
2020
Q1 | $1.33M | Buy |
13,356
+2,692
| +25% | +$348K | 0.08% | 185 |
|
|
2019
Q4 | $1.59M | Buy |
10,664
+400
| +4% | +$54.4K | 0.08% | 194 |
|
|
2019
Q3 | $1.32M | Buy |
10,264
+8,742
| +574% | +$1.17M | 0.07% | 209 |
|
|
2019
Q2 | $210K | Buy |
1,522
+1,095
| +256% | +$147K | 0.01% | 450 |
|
|
2019
Q1 | $61K | Hold |
427
| – | – | ﹤0.01% | 599 |
|
|
2018
Q4 | $53K | Hold |
427
| – | – | ﹤0.01% | 621 |
|
|
2018
Q3 | $71K | Sell |
427
-10
| -2% | -$1.72K | ﹤0.01% | 621 |
|
|
2018
Q2 | $75K | Buy |
437
+27
| +7% | +$4.41K | ﹤0.01% | 597 |
|
|
2018
Q1 | $62K | Hold |
410
| – | – | ﹤0.01% | 642 |
|
|
2017
Q4 | $55K | Sell |
410
-40
| -9% | -$5.55K | ﹤0.01% | 685 |
|
|
2017
Q3 | $66K | Sell |
450
-100
| -18% | -$15.1K | ﹤0.01% | 639 |
|
|
2017
Q2 | $85K | Sell |
550
-60
| -10% | -$9.18K | 0.01% | 589 |
|
|
2017
Q1 | $89K | Sell |
610
-40
| -6% | -$5.21K | 0.01% | 588 |
|
|
2016
Q4 | $71K | Sell |
650
-240
| -27% | -$26.7K | ﹤0.01% | 625 |
|
|
2016
Q3 | $108K | Sell |
890
-150
| -14% | -$20.2K | 0.01% | 531 |
|
|
2016
Q2 | $147K | Sell |
1,040
-20
| -2% | -$2.95K | 0.01% | 481 |
|
|
2016
Q1 | $138K | Sell |
1,060
-23
| -2% | -$2.86K | 0.01% | 490 |
|
|
2015
Q4 | $152K | Sell |
1,083
-217
| -17% | -$30.1K | 0.01% | 466 |
|
|
2015
Q3 | $173K | Buy |
1,300
+30
| +2% | +$5.17K | 0.02% | 439 |
|
|
2015
Q2 | $223K | Sell |
1,270
-25
| -2% | -$4.49K | 0.02% | 413 |
|
|
2015
Q1 | $224K | Buy |
1,295
+20
| +2% | +$3.43K | 0.02% | 409 |
|
|
2014
Q4 | $209K | Sell |
1,275
-1,970
| -61% | -$327K | 0.02% | 414 |
|
|
2014
Q3 | $521K | Buy |
3,245
+1,070
| +49% | +$165K | 0.04% | 290 |
|
|
2014
Q2 | $320K | Buy |
2,175
+2,155
| +10,775% | +$299K | 0.03% | 371 |
|
|
2014
Q1 | $3K | Buy |
+20
| New | +$3.01K | ﹤0.01% | 1114 |
|
Other funds holding JAZZ
VPM
VCM
EC
Central Trust Company's JAZZ Position: Q1 2026 in Review
Central Trust Company reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.13% in Q1 2026, selling an estimated $175 and leaving 742 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #652.
Central Trust Company first reported a position in JAZZ in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.58M in Q2 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Central Trust Company held 742 shares of Jazz Pharmaceuticals worth $140K as of Q1 2026.
- Central Trust Company sold 1 Jazz Pharmaceuticals share in Q1 2026, an estimated $175.
- Jazz Pharmaceuticals made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #652 holding.
- Central Trust Company first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
- Central Trust Company's Jazz Pharmaceuticals position peaked at $2.58M in Q2 2022.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.